Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1371969 | Bioorganic & Medicinal Chemistry Letters | 2009 | 4 Pages |
Abstract
Pyrrole[2,3-d]azepines have been identified as potent agonists of the farnesoid X receptor (FXR). Based on the planar X-ray crystal structure of WAY-362450 1 in the ligand binding domain and molecular modeling studies, non-planar reduced compounds were designed which led to agonists that exhibit high aqueous solubility and retain moderate in vitro potency.
Graphical abstractThe rational design and discovery of a new series of pyrrole[2,3-d]azepino FXR agonists with aqueous solubility and improved pharmaceutical properties is reported.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
John F. Mehlmann, Matthew L. Crawley, Joseph T. Lundquist IV, Ray J. Unwalla, Douglas C. Harnish, Mark J. Evans, Callain Y. Kim, Jay E. Wrobel, Paige E. Mahaney,